Heart Surgery with Kidney Disease.
Chronic kidney disease (CKD) is one of the most significant comorbidities affecting cardiac surgery outcomes. Approximately 25-30% of patients presenting for cardiac surgery have some degree of renal impairment, and patients on dialysis face dramatically elevated surgical risk. The relationship between the heart and kidneys is bidirectional — heart disease accelerates kidney damage, and kidney disease accelerates cardiovascular disease, creating a cycle that complicates both diagnosis and treatment. For cardiac surgery patients with CKD, the concerns are multifaceted: cardiopulmonary bypass can worsen kidney function, fluid management becomes more complex, bleeding risk increases due to uremic platelet dysfunction, and postoperative recovery is prolonged. In patients on dialysis, the operative mortality for CABG is 5 to 10 times higher than in patients with normal kidney function. Despite these challenges, cardiac surgery in CKD patients is not only possible but often necessary — and when performed by experienced teams with appropriate perioperative management, outcomes have improved significantly over the past decade.
What the evidence shows.
Large database studies from the STS National Database show that CKD (defined as GFR below 60 mL/min) increases operative mortality for CABG from approximately 1-2% to 4-8%, depending on the severity of kidney disease. For patients on dialysis, CABG operative mortality ranges from 5-12% across published series, compared to 1-2% for patients with normal renal function. However, contemporary series from high-volume centers demonstrate improving outcomes — a 2022 analysis from the Cleveland Clinic showed dialysis-dependent CABG patients had 30-day mortality of 5.8%, meaningfully better than historical rates of 10-15%. The ISCHEMIA-CKD trial (2020) showed that for patients with stable coronary disease and advanced CKD, an invasive strategy (PCI or CABG) did not reduce the risk of death or MI compared to conservative management — a critical finding that should inform surgical decision-making.
Current recommendations.
Guideline recommendations emphasize careful patient selection and perioperative optimization. For CKD patients with preserved GFR above 30, standard cardiac surgery can be performed with modest additional risk and careful attention to nephroprotective strategies (avoiding nephrotoxic agents, maintaining adequate perfusion pressure, minimizing bypass time). For patients with GFR below 30 or on dialysis, cardiac surgery should be performed only when the expected benefit clearly outweighs the substantially elevated risk, preferably at high-volume centers experienced with this population. Off-pump CABG may offer a renal-protective advantage by avoiding the inflammatory response of cardiopulmonary bypass, though evidence is mixed.
Why this matters for your decision.
CKD patients are at risk of both over-treatment (proceeding with surgery when medical management would be equally effective, as suggested by ISCHEMIA-CKD) and under-treatment (being denied surgery due to perceived risk when the procedure would meaningfully extend life). A second opinion from a Heart Team experienced with CKD patients ensures the surgical decision is calibrated to the individual's renal function trajectory, cardiac disease severity, and overall prognosis.
Need help with this decision?
Our Heart Team evaluates your specific situation with AI-augmented analysis and dual-physician review.